Side-by-side comparison of AI visibility scores, market position, and capabilities
Global hotel company with 7,700+ properties, 1.2M rooms, 22 brands; $11.2B FY2024 revenue; 180M+ Hilton Honors members; 100% asset-light; 490,000-room development pipeline.
Hilton Worldwide Holdings is one of the world's largest and most recognized hotel companies, founded in 1919 by Conrad Hilton in Cisco, Texas and now headquartered in McLean, Virginia, trading on NYSE (HLT). The company manages approximately 7,700 properties with 1.2 million rooms across 22 brands in 126 countries, ranging from the ultra-luxury Waldorf Astoria Collection to extended-stay Home2 Suites by Hilton, all operating under Hilton's 100% asset-light franchise and management model. For FY2024, Hilton generated approximately $11.2 billion in revenues under CEO Christopher Nassetta, with Hilton Honors loyalty membership exceeding 180 million members—the world's largest hotel loyalty program—driving direct booking rates above 70% and reducing dependency on third-party online travel agencies.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.